Healthcare provider profile · identity verified

Eric Gavour, MD

Internal Medicine · KERNERSVILLE, NC · NPI 1821416223

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	676	202
Amlodipine Besylate	Amlodipine Besylate	370	107
Levothyroxine Sodium	Levothyroxine Sodium	333	97
Rosuvastatin Calcium	Rosuvastatin Calcium	303	94
Lisinopril	Lisinopril	288	77
Tamsulosin Hcl	Tamsulosin Hcl	213	64
Omeprazole	Omeprazole	211	66
Losartan Potassium	Losartan Potassium	207	63
Metformin Hcl	Metformin Hcl	184	58
Alprazolam	Alprazolam	173	38
Metoprolol Succinate	Metoprolol Succinate	170	47
Hydrochlorothiazide	Hydrochlorothiazide	162	54
Metformin Hcl Er	Metformin Hcl	155	44
Tizanidine Hcl	Tizanidine Hcl	150	61
Pravastatin Sodium	Pravastatin Sodium	130	40
Pantoprazole Sodium	Pantoprazole Sodium	128	43
Ezetimibe	Ezetimibe	121	33
Glimepiride	Glimepiride	116	33
Furosemide	Furosemide	115	32
Gabapentin	Gabapentin	115	33
Simvastatin	Simvastatin	115	31
Bupropion Xl	Bupropion Hcl	112	31
Fluticasone Propionate	Fluticasone Propionate	105	46
Allopurinol	Allopurinol	102	32
Meloxicam	Meloxicam	100	32
Finasteride	Finasteride	93	28
Trazodone Hcl	Trazodone Hcl	93	32
Albuterol Sulfate Hfa	Albuterol Sulfate	91	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	25
Ozempic	Semaglutide	84	20
Atenolol	Atenolol	80	24
Carvedilol	Carvedilol	80	26
Metoprolol Tartrate	Metoprolol Tartrate	80	24
Duloxetine Hcl	Duloxetine Hcl	71	19
Montelukast Sodium	Montelukast Sodium	70	22
Prednisone	Prednisone	69	54
Sertraline Hcl	Sertraline Hcl	67	18
Doxycycline Hyclate	Doxycycline Hyclate	66	53
Famotidine	Famotidine	66	24
Escitalopram Oxalate	Escitalopram Oxalate	65	20
Zolpidem Tartrate	Zolpidem Tartrate	63	13
Warfarin Sodium	Warfarin Sodium	61	16
Citalopram Hbr	Citalopram Hydrobromide	57	17
Eliquis	Apixaban	57	19
Fluoxetine Hcl	Fluoxetine Hcl	55	17
Triamcinolone Acetonide	Triamcinolone Acetonide	54	18
Buspirone Hcl	Buspirone Hcl	50	12
Hydralazine Hcl	Hydralazine Hcl	50	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	18
Meclizine Hcl	Meclizine Hcl	46	15
Potassium Chloride	Potassium Chloride	46	16
Pioglitazone Hcl	Pioglitazone Hcl	43	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	11
Clonazepam	Clonazepam	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	13
Glipizide Er	Glipizide	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	11
Terazosin Hcl	Terazosin Hcl	34	suppressed
Chlorthalidone	Chlorthalidone	33	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	32	21
Alendronate Sodium	Alendronate Sodium	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	11
Oxybutynin Chloride Er	Oxybutynin Chloride	31	12
Spironolactone	Spironolactone	31	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	28
Jardiance	Empagliflozin	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	11
Januvia	Sitagliptin Phosphate	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	11
Synthroid	Levothyroxine Sodium	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Naproxen	Naproxen	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Nitroglycerin	Nitroglycerin	19	11
Valsartan	Valsartan	19	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	11
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Baclofen	Baclofen	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Nystatin	Nystatin	12	suppressed
Olanzapine Odt	Olanzapine	12	suppressed
Topiramate	Topiramate	12	suppressed
Colchicine	Colchicine	11	suppressed
Constulose	Lactulose	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed
Temazepam	Temazepam	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error